These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31367007)

  • 21. Dicer regulates differentiation and viability during mouse pancreatic cancer initiation.
    Morris JP; Greer R; Russ HA; von Figura G; Kim GE; Busch A; Lee J; Hertel KJ; Kim S; McManus M; Hebrok M
    PLoS One; 2014; 9(5):e95486. PubMed ID: 24788257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
    Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
    Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis.
    Brunet M; Vargas C; Fanjul M; Varry D; Hanoun N; Larrieu D; Pieruccioni L; Labrousse G; Lulka H; Capilla F; Ricard A; Selves J; Couvelard A; Gigoux V; Cordelier P; Guillermet-Guibert J; Dufresne M; Torrisani J
    J Pathol; 2024 Aug; 263(4-5):466-481. PubMed ID: 38924548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Let-7b and miR-495 stimulate differentiation and prevent metaplasia of pancreatic acinar cells by repressing HNF6.
    Prévot PP; Augereau C; Simion A; Van den Steen G; Dauguet N; Lemaigre FP; Jacquemin P
    Gastroenterology; 2013 Sep; 145(3):668-78.e3. PubMed ID: 23684747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia.
    Greer RL; Staley BK; Liou A; Hebrok M
    Gastroenterology; 2013 Nov; 145(5):1088-1097.e8. PubMed ID: 23891977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia.
    Pitarresi JR; Liu X; Sharma SM; Cuitiño MC; Kladney RD; Mace TA; Donohue S; Nayak SG; Qu C; Lee J; Woelke SA; Trela S; LaPak K; Yu L; McElroy J; Rosol TJ; Shakya R; Ludwig T; Lesinski GB; Fernandez SA; Konieczny SF; Leone G; Wu J; Ostrowski MC
    Neoplasia; 2016 Sep; 18(9):541-52. PubMed ID: 27659014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas.
    Saponara E; Visentin M; Baschieri F; Seleznik G; Martinelli P; Esposito I; Buschmann J; Chen R; Parrotta R; Borgeaud N; Bombardo M; Malagola E; Caflisch A; Farhan H; Graf R; Sonda S
    J Pathol; 2018 Nov; 246(3):352-365. PubMed ID: 30058725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice.
    Erener S; Ellis CE; Ramzy A; Glavas MM; O'Dwyer S; Pereira S; Wang T; Pang J; Bruin JE; Riedel MJ; Baker RK; Webber TD; Lesina M; Blüher M; Algül H; Kopp JL; Herzig S; Kieffer TJ
    Cell Rep Med; 2021 Nov; 2(11):100434. PubMed ID: 34841287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Niu N; Lu P; Yang Y; He R; Zhang L; Shi J; Wu J; Yang M; Zhang ZG; Wang LW; Gao WQ; Habtezion A; Xiao GG; Sun Y; Li L; Xue J
    Gut; 2020 Apr; 69(4):715-726. PubMed ID: 31300513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer.
    Azizi N; Toma J; Martin M; Khalid MF; Mousavi F; Win PW; Borrello MT; Steele N; Shi J; di Magliano MP; Pin CL
    Oncogene; 2021 Apr; 40(17):3118-3135. PubMed ID: 33864001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice.
    Zhuang L; Zhan X; Bi Y; Ji B
    Methods Mol Biol; 2019; 1882():287-297. PubMed ID: 30378063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.
    Quattrochi B; Gulvady A; Driscoll DR; Sano M; Klimstra DS; Turner CE; Lewis BC
    Oncotarget; 2017 May; 8(22):35902-35918. PubMed ID: 28415794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
    Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
    Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions.
    Lubeseder-Martellato C; Alexandrow K; Hidalgo-Sastre A; Heid I; Boos SL; Briel T; Schmid RM; Siveke JT
    EBioMedicine; 2017 Feb; 15():90-99. PubMed ID: 28057438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia.
    Ebine K; Chow CR; DeCant BT; Hattaway HZ; Grippo PJ; Kumar K; Munshi HG
    Sci Rep; 2016 Jul; 6():29133. PubMed ID: 27364947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
    Felix TF; Lopez Lapa RM; de Carvalho M; Bertoni N; Tokar T; Oliveira RA; M Rodrigues MA; Hasimoto CN; Oliveira WK; Pelafsky L; Spadella CT; Llanos JC; F Silva G; Lam WL; Rogatto SR; Amorim LS; Drigo SA; Carvalho RF; Reis PP
    PLoS One; 2019; 14(5):e0217421. PubMed ID: 31150430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.